DFX Intelligence

Data Factory

Outro

Evidence-based antidepressant tapering by expert clinicians. Co-founded by world-leading expert Dr. Mark Horowitz, Outro helps you safely come off your medication with personalized taper plans, wrap-around support and custom dose sizes.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:4612f74f-6645-4f82-b2b8-3545449b9155

Data as of Sep 19, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 8:16 PM UTC and rebuilt at most every 15 minutes.

Relationships: 2
Dated events: 0
On other graphs: 0
Observed: Sep 13, 2026 to Sep 19, 2026
7 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 2
People: 0
Website: outro.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
K50 Ventures	Micro VC	n/a	n/a	unknown	Unknown
Hannah Grey Ventures, LLC	Seed fund manager	n/a	n/a	unknown	Unknown

Relationships

Invested in (2)

← Hannah Grey Ventures, LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← K50 VenturesFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:4612f74f-6645-4f82-b2b8-3545449b9155
First observed: Sep 13, 2026
Last observed: Sep 19, 2026 40 h ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.